Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis
Open Access
- 1 October 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 12 (10) , 1381-1388
Abstract
Tumor necrosis factor receptor-1 (TNFR1, CD120a) has been implicated in the pathogenesis of several experimental models of T cell-mediated autoimmune disorders, but its role in antibody-mediated autoimmune diseases has not been addressed. Experimental autoimmune myasthenia gravis (EAMG), an autoantibody-mediated T cell-dependent neuromuscular disorder, represents an animal model for myasthenia gravis in human. To investigate the role of TNFR1 in the pathogenesis of EAMG, TNFR1–/– and wild-type mice were immunized with Torpedo acetylcholine receptor (AChR) in complete Freund's adjuvant. TNFR1–/– mice failed to develop EAMG. Lymphoid cells from TNFR1–/– mice produced low amounts of Th1 (IFN-γ, IL-2 and IL-12)-type cytokines, but elevated levels of Th2 (IL-4 and IL-10)-type cytokines compared with lymphoid cells of wild-type mice. Accordingly, the levels of anti-AChR IgG2 antibodies were severely reduced and the level of anti-AChR IgG1 antibodies were moderately reduced. Co-injection of recombinant mouse IL-12 with AChR in adjuvant restored T cell responses to AChR and promoted development of EAMG in TNFR1–/– mice. These results demonstrate that the TNF/TNFR1 system is required for the development of EAMG. The lack of a functional TNF/TNFR1 system can, at least in part, be substituted by IL-12 at the stage of initial priming with AChR and adjuvant.Keywords
This publication has 34 references indexed in Scilit:
- Tumor necrosis factor‐a and the progression of diabetes in non‐obese diabetic miceImmunological Reviews, 1999
- Interferon γ (IFN-γ) Is Necessary for the Genesis of Acetylcholine Receptor–induced Clinical Experimental Autoimmune Myasthenia gravis in MiceJournal of Experimental Medicine, 1997
- Prevention of autoimmune diabetes mellitus in NOD mice by transgenic expression of soluble tumor necrosis factor receptor p55European Journal of Immunology, 1997
- Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling.Journal of Experimental Medicine, 1996
- Myasthenia GravisNew England Journal of Medicine, 1994
- Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenesNature, 1993
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- Defective T lymphocyte function in nonthymectomized patients with myasthenia gravisClinical Immunology and Immunopathology, 1991
- Cell surface expression of the 70-kD component of Ku, a DNA-binding nuclear autoantigen.Journal of Clinical Investigation, 1990
- Experimental myasthenia gravis. A murine system.Journal of Experimental Medicine, 1980